Personalized Brain Energy Optimization System

A system for tailoring medium-chain triglyceride compositions to individual brain energy needs, utilizing genetic profiling, neuroimaging, and wearable devices to optimize brain function and treat neurological disorders.

The original patent disclosed the use of medium-chain triglycerides for treating brain energy deficiency conditions. However, it did not address the need for personalized treatment approaches, which can lead to varying degrees of efficacy and potential side effects. The present inventive concept addresses this limitation by introducing a system that integrates genetic profiling, neuroimaging, and wearable devices to provide customized MCT compositions and real-time monitoring of brain energy levels.

The system comprises a genetic profiling module that analyzes an individual's genetic predispositions to brain energy metabolism, a neuroimaging module that uses functional magnetic resonance imaging (fMRI) and/or electroencephalography (EEG) to assess brain energy metabolism, and a wearable device that monitors brain energy levels in real-time. Based on this data, the system formulates a customized MCT composition tailored to the individual's specific brain energy needs. The wearable device can adjust the composition and dosage of MCTs in response to changes in brain energy levels, ensuring optimal treatment outcomes.

The present inventive concept introduces a paradigm shift in the use of medium-chain triglycerides for brain energy optimization. The integration of genetic profiling, neuroimaging, and wearable devices enables personalized treatment approaches that were not possible with the original patent. The inventive concept's ability to provide real-time monitoring and adjustment of MCT compositions represents a significant improvement over existing methods.

Alternative embodiments of the inventive concept could include the use of other neuroimaging modalities, such as magnetoencephalography (MEG) or positron emission tomography (PET), or the integration of other therapeutic modalities, such as transcranial magnetic stimulation (TMS) or cognitive training. The system could also be adapted for use in other conditions, such as Alzheimer's disease or Parkinson's disease.

The personalized brain energy optimization system has significant commercial potential in the treatment of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and attention deficit hyperactivity disorder (ADHD). The system could also be marketed for use in healthy individuals seeking to optimize their brain function and cognitive performance. The market for such a system is expected to be substantial, given the growing demand for personalized medicine and the increasing awareness of the importance of brain health.